Stay updated with breaking news from Nasdaq Pmvp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Additionally, the 36-month beta value for PMVP is 0.93. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.” The average price predicted by analysts
PMV Pharmaceuticals Inc (NASDAQ: PMVP) has experienced a decline in its stock price by -26.01 compared to its previous closing price of 6.42. However, the company has seen a fall of -18.80% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-11 that PRINCETON, N.J., Oc
The stock of PMV Pharmaceuticals Inc. (PMVP) has seen a 3.28% increase in the past week, with a -11.75% drop in the past month, and a 11.66% flourish in the past quarter. The volatility ratio for the week is 8.71%, and the volatility levels for the past 30 days are at 6.84% for PMVP. The simple movi
PMV Pharmaceuticals (NASDAQ:PMVP – Free Report) had its price target lowered by HC Wainwright from $35.00 to $29.00 in a research report sent to investors on Friday morning, Marketbeat Ratings reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for PMV Pharmaceuticals’ FY2024 earnings at ($2.02) EPS. PMV […]
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Free Report) – Research analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of PMV Pharmaceuticals in a report released on Friday, August 11th. HC Wainwright analyst R. Burns forecasts that the company will post earnings per share of ($2.02) for the year. HC Wainwright […]